Loading...
Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
OBJECTIVE: Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis. In May 2018, denosumab was approved for the treatment of GIOP in men and women at high risk of fracture. We undertook a systematic review and meta-analysis to summarize the efficacy and safety of...
Na minha lista:
| Udgivet i: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6698580/ https://ncbi.nlm.nih.gov/pubmed/31616133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S148654 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|